DIASORIN S.P.A. |
Market Closed -
Other stock markets
|
After market 03:59:59 pm | |||
| 98.34 EUR | -1.07% |
|
97.73 | -0.62% |
| May. 21 | Citadel Advisors moves on Saipem and Biesse. | AN |
| May. 20 | DiaSorin takes over shares for more than EUR8 million | AN |
This Alphavalue article, the European leader in independent research, is only available to subscribers .Alphavalue is exclusively on MarketScreener. To unlock the article, SUBSCRIBE!
Already a customer? Log In
DiaSorin S.p.A. specializes in the development, manufacturing and marketing of in vitro diagnostic reagents. The products are used in treating infectious and viral diseases, thyroid pathologies, cancer, etc.
At the end of 2023, the group had 10 production sites located in Italy, the United States (6), Canada, Germany, and the United Kingdom.
Calendar
2024-06-05
- Jefferies Global Healthcare Conference
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
12
Last Close Price
98.34
EUR
Average target price
100.1
EUR
Spread / Average Target
+1.76%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +5.47% | 5.74B | |
| -5.86% | 12.09B | |
| -4.87% | 8.21B | |
| +27.42% | 5.64B | |
| -9.89% | 4.16B | |
| -58.99% | 2.88B | |
| +8.97% | 2.69B | |
| -5.19% | 2.33B | |
| +21.58% | 2.17B | |
| -6.23% | 1.86B |
- Stock Market
- Equities
- DIA Stock
- News DiaSorin S.p.A.
- DiaSorin: Markets hailed the Q1 beat; guidance re-affirmed
